Quantiphi, DDReg Partner to Transform Regulatory Reporting in Life Sciences Through AI

MARLBOROUGH, Mass., Nov. 5, 2024 /PRNewswire/ — Quantiphi, a global AI-first digital engineering company and DDReg, a global leader in regulatory expertise today announced a partnership that will address regulatory challenges that pharmaceutical companies, biotechnology firms, medical device and cosmetics manufacturers face by bringing innovations to market more quickly through AI.

Quantiphi Global Head of Healthcare and Life Sciences Barinder Marhok said the partnership marries DDReg’s expertise in global regulatory process management and securing and renewing government approvals for healthcare interventions with Quantiphi’s expertise in AI-managed processes and documents.

“As the life sciences industry grapples with the ever-evolving regulation landscape, Quantiphi and DDReg have come together to help deliver cutting-edge solutions that streamline regulatory processes across both the drug development and commercialization lifecycle, ultimately helping improve more lives,” Marhok said. “Leveraging cloud, data and AI technologies, our joint efforts aim to accelerate approvals, enhance compliance and optimize Life Cycle Management (LCM), ensuring a faster and more efficient path to market.”

DDReg Managing Director Neeti Pant said “Our collaboration harnesses DDReg’s unparalleled regulatory knowledge and Quantiphi’s innovative technology, along with a deep understanding of artificial intelligence to revolutionize regulatory processes. Together, we are transforming how the life sciences sector navigates some of its most pressing regulatory challenges, ensuring compliance, enhancing safety and accelerating the time to market for new therapies. This collaboration will not only address current regulatory demands but also anticipate future needs, providing a framework for sustainable growth and innovation. By combining our strengths, we are paving the way for a more streamlined, effective, proactive and cost-efficient approach to regulatory affairs in the life sciences industry.”

Learn more about Quantiphi’s responsible AI products, platforms and solutions.

About Quantiphi
Quantiphi is an award-winning AI-first digital engineering company driven by the desire to reimagine and realize transformational opportunities at the heart of the business. Since its inception in 2013, Quantiphi has solved the toughest and most complex business problems by combining deep industry experience, disciplined cloud and data engineering practices, and cutting-edge artificial intelligence research to achieve accelerated and quantifiable business results. Learn more at Quantiphi.com and follow us on Linkedin, X, formerly Twitter and Instagram.

Media Contact:
H. Mayes
contact.newsroom@quantiphi.com
Quantiphi Newsroom

View original content to download multimedia:https://www.prnewswire.com/news-releases/quantiphi-ddreg-partner-to-transform-regulatory-reporting-in-life-sciences-through-ai-302296011.html

SOURCE Quantiphi

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

1 day ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

1 day ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago

Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton)…

2 days ago